References
- Blank M S, Roberts D L. Antagonist of gonadotropin-releasing hormone blocks naloxone-induced elevations in serum luteinizing hormone. Neuroendocrinology 1982; 35: 309–314
- Bruni J F, Van Vugt D, Marshall S, Meites J. Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone follicle stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci 1977; 21: 461–466
- Cicero T J, Schainker B A, Meyer E R. Endogenous opiates participate in the regulation of the hypothalamic pituitary luteinizing hormone: axis and testosterone's negative feedback control of luteinizing hormone. Endocrinology 1979; 104: 1286–1291
- Cicero T J, Wilcox C E, Bell R D, Meyer E R. Naloxone-induced increases in serum luteinizing hormone in the male: mechanisms of action. J Pharmacol Exp Ther 1980; 212: 573–578
- DuPont A, Cusan L, Garon M, Labrie F, Li C H. P-Endorphin stimulation of growth hormone release in vivo. Proc Natl Acad Sci USA 1977; 74: 358–360
- Fraioli F, Panerai A E, Santoro C, Fabbri A, Santoro F, Isidori A. Control of gonadotropin secretion in man: role of opioid peptides. Horm Metab Res 1982; 16: 312–317
- Goldstein A. Opioid peptides (endorphins) in pituitary and brain. Science 1976; 163: 1081–1086
- Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res 1975; 88: 295–308
- Hughes J, Smith T W, Kosterlitz H W, Fothergill L A, Morgan B A, Morris H R. Identification of two related peptides from the brain with potent opiate antagonist activity. Nature 1975; 258: 577–579
- Karla S P. Neural loci involved in naloxone-induced luteinizing hormone release: effects of a norepinephrine synthesis inhibitor. Endocrinology 1981; 109: 1805–1810
- Ling N, Burgus R, Guillemin R. Isolation, primary structure and synthesis of α-endorphin, and γ-endorphin, two peptides of hypothalamic-hypophysial origin with morphomimetic activity. Proc Natl Acad Sci USA 1976; 73: 3942–3946
- Martin W R. Naloxone. Ann Intern Med 1984; 85: 765–768
- Morley J E, Baranetsky N G, Wingert T D, et al. Endocrine effect of naloxone-induced opiate receptor blockade. J Clin Endocrinol Metab 1980; 50: 251–257
- Pfeiffer W R, Herz A. Endocrine actions of opioids. Horm Metabol Res 1984; 16: 386–397
- Rivier C, Vale W, Ling N, Brown M, Guillemin R. Stimulation in vivo of the secretion of prolactin and growth hormone by p-endorphin. Endocrinology 1977; 100: 238–241
- Sawynoc J, Pinsky C, La Bella F S. Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 1979; 25: 1621–1623
- Veldhuis J D, Rogol A D, Johnson M J, Dufau M L. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man. J Clin Invest 1983; 72: 2031–2040